Rheumatoid Arthritis (RA) Prevention

• Context (TH): The Lancet published a study related to the repurposing of an existing drug, Abatacept, to prevent the onset of rheumatoid arthritis.
• The study aimed to evaluate the feasibility, efficacy, and acceptability of treating high-risk individuals with Abatacept.
• Abatacept acts as a signalling pathway to initiate the appropriate immune response.
• High-risk individuals for RA can be identified years before developing the disease through the detection of autoantibodies associated with RA.
• The study showed that targeting adaptive immunity with Abatacept in high-risk individuals can prevent the onset of RA.
• Abatacept, classified as a biological drug, is not available in India due to poor sales.
• Early prevention of RA is significant, especially for individuals with a family history.
• There are challenges in convincing individuals with blood abnormalities but no physical symptoms to start preventive treatment.

Rheumatoid Arthritis

• RA is a chronic autoimmune condition primarily affecting the joints.
• It leads to pain, joint swelling, stiffness, and reduced mobility.
• While the exact cause of RA remains unclear, the immune system mistakenly attacks the body’s tissues, resulting in joint damage.
• RA can also impact other organs like the heart, lungs, and skin.
• RA can significantly reduce a patient’s quality of life and may lead to medical problems outside the joints.
• Lifestyle changes such as quitting smoking, regular exercise, and a healthy diet are recommended on a mass scale to reduce the risk of RA.
• Maintaining adequate vitamin D levels may help regulate the immune response and reduce inflammation associated with RA.